REGN common stock issued history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Common Stock Issued — Trailing twelve months (TTM) (USD)
Period ending	Common Stock Issued (USD)
Jun 30, 2026	756,100,000
Mar 31, 2026	738,400,000
Dec 31, 2025	635,900,000
Sep 30, 2025	223,300,000
Jun 30, 2025	437,700,000
Mar 31, 2025	843,800,000
Dec 31, 2024	1,465,300,000
Sep 30, 2024	1,675,400,000
Jun 30, 2024	1,689,300,000
Mar 31, 2024	1,342,400,000
Dec 31, 2023	1,145,500,000
Sep 30, 2023	1,217,100,000
Jun 30, 2023	1,267,000,000
Mar 31, 2023	1,483,100,000
Dec 31, 2022	1,519,500,000
Sep 30, 2022	1,689,600,000
Jun 30, 2022	2,192,500,000
Mar 31, 2022	2,098,900,000
Dec 31, 2021	1,672,300,000
Sep 30, 2021	1,233,700,000
Jun 30, 2021	715,400,000
Mar 31, 2021	1,858,800,000
Dec 31, 2020	2,575,200,000
Sep 30, 2020	2,519,400,000
Jun 30, 2020	2,224,700,000
Mar 31, 2020	882,600,000
Dec 31, 2019	211,800,000
Sep 30, 2019	190,592,000
Jun 30, 2019	235,492,000
Mar 31, 2019	241,692,000
Dec 31, 2018	114,519,000
Sep 30, 2018	100,748,000
Jun 30, 2018	85,647,000
Mar 31, 2018	236,967,000
Dec 31, 2017	240,213,000
Sep 30, 2017	263,854,000
Jun 30, 2017	251,826,000
Mar 31, 2017	104,108,000
Dec 31, 2016	126,739,000
Sep 30, 2016	145,712,000
Jun 30, 2016	154,139,000
Mar 31, 2016	169,389,000
Dec 31, 2015	206,358,000
Sep 30, 2015	195,664,000
Jun 30, 2015	178,813,000
Mar 31, 2015	147,276,000
Dec 31, 2014	126,045,000
Sep 30, 2014	96,479,000
Jun 30, 2014	86,150,000
Mar 31, 2014	99,471,000
Dec 31, 2013	57,393,000
Sep 30, 2013	56,827,000
Jun 30, 2013	58,218,000
Mar 31, 2013	44,685,000
Dec 31, 2012	63,549,000
Sep 30, 2012	42,960,000
Jun 30, 2012	45,785,000
Mar 31, 2012	52,077,000
Dec 31, 2011	33,592,000
Sep 30, 2011	222,102,000
Jun 30, 2011	212,164,000
Mar 31, 2011	200,907,000
Dec 31, 2010	196,790,000
Sep 30, 2010	17,732,000
Jun 30, 2010	18,957,000
Mar 31, 2010	16,786,000
Dec 31, 2009	8,598,000
Sep 30, 2009	6,410,000
Jun 30, 2009	5,969,000
Mar 31, 2009	7,084,000
Dec 31, 2008	7,949,000
Sep 30, 2008	320,394,000
Jun 30, 2008	318,261,000
Mar 31, 2008	319,345,000
Dec 31, 2007	319,400,000
Sep 30, 2007	185,296,000
Jun 30, 2007	186,019,000
Mar 31, 2007	183,550,000
Dec 31, 2006	185,008,000
Sep 30, 2006	7,842,000
Jun 30, 2006	6,862,000
Mar 31, 2006	6,467,000
Dec 31, 2005	4,081,000
Sep 30, 2005	1,941,000
Jun 30, 2005	1,931,000
Mar 31, 2005	2,258,000
Dec 31, 2004	1,502,000
Sep 30, 2004	845,000
Jun 30, 2004	46,205,000
Mar 31, 2004	46,366,000
Dec 31, 2003	94,678,000
Sep 30, 2003	95,197,000
Jun 30, 2003	49,796,000
Mar 31, 2003	49,567,000
Dec 31, 2002	2,149,000
Sep 30, 2002	1,638,000
Jun 30, 2002	2,145,000
Mar 31, 2002	5,308,000
Dec 31, 2001	158,522,000
Sep 30, 2001	158,513,000